1.80
-0.04 (-2.17%)
| Penutupan Terdahulu | 1.84 |
| Buka | 1.84 |
| Jumlah Dagangan | 560,682 |
| Purata Dagangan (3B) | 858,767 |
| Modal Pasaran | 231,614,176 |
| Harga / Jualan (P/S) | 0.500 |
| Harga / Buku (P/B) | 1.51 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2026 |
| Margin Keuntungan | -3.46% |
| Margin Operasi (TTM) | -23.28% |
| EPS Cair (TTM) | -0.160 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -21.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 289.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.58% |
| Nisbah Semasa (MRQ) | 4.12 |
| Aliran Tunai Operasi (OCF TTM) | 4.43 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.36 M |
| Pulangan Atas Aset (ROA TTM) | 0.70% |
| Pulangan Atas Ekuiti (ROE TTM) | -4.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Organogenesis Holdings Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.86 |
|
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 46.49% |
| % Dimiliki oleh Institusi | 54.09% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |